According to a new report by Polaris Market Research, the global gRNA market was valued at USD 645.5 million in 2024 and is projected to reach USD 3,750.8 million by 2034, expanding at a CAGR of 20.40% over the forecast period. Growth is underpinned by rapid advances in CRISPR-based gene editing, rising R&D investment in genetic therapies, and expanding demand for functional genomics research across key end-use industries.

What Is Driving gRNA Market Growth?

Demand is climbing as accelerating genomics and proteomics research converges with the growing clinical pursuit of personalized medicine. Researchers and biopharma companies are prioritizing precise, programmable gene editing, pushing gRNA adoption across drug discovery, cell-line engineering, and diagnostics. Polaris analysts note that guide RNA's unique ability to direct CRISPR-Cas systems to specific DNA sequences positions the segment for sustained high growth through 2034, with pharmaceutical and biotechnology companies emerging as a leading revenue contributor and custom gRNA synthesis services posting some of the fastest incremental gains.

Key Trends Shaping the gRNA Industry

Innovations in Proteomics and Genomics Research

Large-scale genomics and proteomics R&D programs increasingly rely on gRNA to knock out or modulate specific genes, streamlining target identification and validation. This functional genomics work is deepening the understanding of gene function and disease mechanisms, reinforcing gRNA's role as a core research reagent.

Rising Necessity of Personalized Treatment

The application of gRNA technology has advanced on two fronts: rapid CRISPR-based diagnostic tests and CRISPR-based antiviral therapeutic research. Heightened public awareness of gene-editing technology, combined with growing recognition that patients respond differently to the same treatment, continues to expand market demand for tailored, gRNA-enabled solutions.

Capacity Expansion and Investment Momentum

Funding and infrastructure activity are accelerating. In July 2025, BioSpring announced plans to build one of the world's largest RNA manufacturing facilities dedicated to pharmaceutical-grade guide RNAs, while AIRNA secured USD 155 million in Series B financing in April 2025 to advance its guide-RNA-enabled therapeutic pipeline — both signaling growing confidence in gRNA's clinical-stage potential.

Market Segmentation: Breaking Down the gRNA Market

Polaris segments the gRNA market by product & services, gRNA type, application, end-use, and region, giving each buyer persona a standalone, citable data point.

By Product & Services

The products segment led the gRNA market in 2023, favored by researchers for its high accuracy, efficiency, and specificity in gene editing. The custom gRNA synthesis services segment is projected to grow at the fastest pace as biotechnology companies offer researchers tailored design, synthesis, and delivery options for specific experimental needs.

By gRNA Type

The research-use segment accounted for the largest share in 2023, driven by widespread CRISPR/Cas9 adoption across academic and industry research programs. The GMP-grade segment is expected to grow at the fastest rate as demand rises for gRNA manufactured under rigorous quality standards for clinical trials and patient treatment.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/grna-market

By Application

Genome engineering remains a leading application area, supported by broad use in gene therapy and cell-line development, while disease model studies and functional genomics continue to gain share as pharmaceutical R&D pipelines expand, signaling where near-term demand for research-grade and GMP-grade gRNA is shifting.

By End-Use

Pharmaceutical and biotechnology companies represent a major end-use category, reflecting the sector's heavy reliance on gRNA for drug discovery and therapeutic development, while academic research institutes and CMOs/CROs continue to broaden the market's end-use base.

Regional Outlook: Where Is the gRNA Market Growing Fastest?

North America led the market in 2024, supported by a strong concentration of key players and substantial R&D investment, while Asia Pacific is expected to post the fastest CAGR through 2034, driven by a large target population, rapid technology adoption, and Chinese government policies offering tax incentives and streamlined regulatory pathways for biotech investment. Within North America, the U.S. remains the largest single market; within Asia Pacific, China is the primary growth engine. Europe rounds out the top three, supported by established life sciences infrastructure.

Competitive Landscape: Leading gRNA Companies

Key players profiled in the report include Agilent Technologies Inc., GENEWIZ (Azenta Life Sciences), Synthego, Thermo Fisher Scientific Inc., and Merck KGaA, among others, who are focusing on licensing partnerships and capacity expansion to strengthen market position across the products and research-use segments outlined above. Recent moves include BioSpring's large-scale RNA manufacturing investment and AIRNA's Series B financing round, both aimed at deepening share in the guide-RNA therapeutics pipeline.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the gRNA market, this report benchmarks market share, segment-level pricing, and forecast data — by product & services, gRNA type, application, end-use, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking GMP-grade gRNA as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Digital Signature Market

Flavors Market

Baby Sitting Services Market

Growing Concerns over Food Waste Globally to Boost Market

Conveying Equipment Market

Conveying Equipment Market

Electric Ac Motors Market

Amphoteric Surfactants Market

Biocides Market